Suppr超能文献

新型日本风疹疫苗:对比试验

New Japanese rubella vaccine: comparative trials.

作者信息

Best J M, Banatvala J E, Bowen J M

出版信息

Br Med J. 1974 Jul 27;3(5925):221-4. doi: 10.1136/bmj.3.5925.221.

Abstract

A total of 142 seronegative volunteers were given one of the following rubella vaccines: Cendehill, HPV77. DE-5, RA27/3, or a new Japanese vaccine, To-336. To-336 vaccine produced a slightly higher geometric mean antibody titre (G.M.T.) (65.7) than did the HPV77. DE-5 (63.1) or RA27/3 vaccine (61.9) but the G.M.T. induced by Cendehill vaccine was much lower (39.3).Reactions, particularly joint symptoms, occurred least commonly after vaccination with To-336 vaccine. Joint symptoms occurred within seven days of menstruation in 30 out of 37 (81%) vaccines (P <0.01); their incidence was not related to oral contraception.Though there is evidence to suggest that Japanese virus strains may be non-teratogenic further data on the incidence of congenitally acquired infection in Japan must be collected before this conclusion can be supported on epidemiological grounds.

摘要

总共142名血清反应阴性的志愿者接种了以下风疹疫苗之一:Cendehill、HPV77、DE-5、RA27/3或一种新的日本疫苗To-336。To-336疫苗产生的几何平均抗体滴度(G.M.T.)(65.7)略高于HPV77、DE-5(63.1)或RA27/3疫苗(61.9),但Cendehill疫苗诱导的G.M.T.要低得多(39.3)。接种To-336疫苗后反应,尤其是关节症状,出现得最少。37名接种疫苗者中有30名(81%)在月经七天内出现关节症状(P<0.01);其发生率与口服避孕药无关。虽然有证据表明日本病毒株可能无致畸性,但在基于流行病学依据支持这一结论之前,必须收集日本先天性感染发生率的更多数据。

相似文献

1
New Japanese rubella vaccine: comparative trials.新型日本风疹疫苗:对比试验
Br Med J. 1974 Jul 27;3(5925):221-4. doi: 10.1136/bmj.3.5925.221.
3
Rubella vaccination: persistence of antibodies for up to 16 years.风疹疫苗接种:抗体可持续长达16年。
Br Med J (Clin Res Ed). 1982 Jul 24;285(6337):253-5. doi: 10.1136/bmj.285.6337.253.
7
Clinical evaluation of rubella vaccine, Cendehill strain.风疹疫苗Cendehill株的临床评估
South Med J. 1970 Apr;63(4):371-5. doi: 10.1097/00007611-197004000-00005.

引用本文的文献

3
Rubella virus and chronic joint disease: is there an association?风疹病毒与慢性关节疾病:存在关联吗?
J Clin Microbiol. 1998 Dec;36(12):3524-6. doi: 10.1128/JCM.36.12.3524-3526.1998.
5
Rubella vaccination: persistence of antibodies for up to 16 years.风疹疫苗接种:抗体可持续长达16年。
Br Med J (Clin Res Ed). 1982 Jul 24;285(6337):253-5. doi: 10.1136/bmj.285.6337.253.
8
Rubella vaccines: past, present and future.风疹疫苗:过去、现在与未来。
Epidemiol Infect. 1991 Aug;107(1):17-30. doi: 10.1017/s0950268800048640.
9
Role of rubella in congenital malformations in India.风疹在印度先天性畸形中的作用。
J Hyg (Lond). 1976 Feb;76(1):33-40. doi: 10.1017/s0022172400054917.

本文引用的文献

4
Rubella vaccination in adult females.成年女性的风疹疫苗接种
N Engl J Med. 1969 Mar 27;280(13):682-5. doi: 10.1056/NEJM196903272801302.
5
Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.
Am J Epidemiol. 1971 Sep;94(3):246-51. doi: 10.1093/oxfordjournals.aje.a121318.
10
Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines.
Am J Dis Child. 1969 Aug;118(2):237-43. doi: 10.1001/archpedi.1969.02100040239015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验